<DOC>
	<DOCNO>NCT02537574</DOCNO>
	<brief_summary>This study evaluate safety , effectiveness tolerance low dose oral naltrexone along buprenorphine treat opioid use disorder prior first injection VIVITROL .</brief_summary>
	<brief_title>Naltrexone Use Conjunction With Buprenorphine Adults With Opioid Use Disorder Prior First Dose VIVITROLÂ® ( Naltrexone Extended-Release Injectable Suspension )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Willing able provide inform consent Willing able provide governmentissued identification Has BMI 18.040.0 kg/m^2 Has physiologic dependence opioids Is voluntarily seek treatment opioid use disorder willing completely withdraw his/her opioid use throughout study desire motivation antagonist therapy Wiling abide contraception requirement duration study Additional criterion may apply Is pregnant , plan become pregnant breastfeeding study Has use Buprenorphine within 7 day prior randomization Has use Methadone within 14 day prior randomization Has history VIVITROL use within 90 day prior screen use oral naltrexone within 14 day prior randomization Has history seizure receive anticonvulsant therapy within past 5 year Has condition , disease state , previous medical history would preclude safe participation study affect ability adhere protocol visit schedule , requirement , assessment Has current diagnosis schizoaffective disorder , bipolar disorder , untreated unstable major depressive disorder Is currently physiologically dependent psychoactive substance ( except opioids , caffeine , nicotine ) require medical intervention detoxification Has history hypersensitivity adverse reaction Buprenorphine , Naltrexone , Naloxone Has history 3 unsuccessful inpatient medically assist outpatient opioid detoxification his/her lifetime Has significant suicidal ideation behavior within past year Is currently participate , participate , clinical trial investigational drug , device , biologics within 3 month prior screen Has history accidental opioid drug overdose past 3 year whether medical treatment seek receive Is court mandate receive treatment opioid use disorder Additional criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Alkermes</keyword>
	<keyword>Buprenorphine</keyword>
	<keyword>Naltrexone</keyword>
	<keyword>Vivitrol</keyword>
	<keyword>Opioid Use</keyword>
	<keyword>Opiates</keyword>
	<keyword>Dependence</keyword>
	<keyword>Abuse</keyword>
	<keyword>Heroin</keyword>
	<keyword>Painkillers</keyword>
	<keyword>Substance Abuse</keyword>
</DOC>